Notice

Admission to mFund Settlement Service of the New Capital China Equity Fund (ASX: NCE01)

What's this about:
  • Settlement
  • Product
  • Operations
  • Market Data
  • Compliance
  • Exchange Traded Products (ETP) & mFund
  • Schedule 10A
  • AQUA Products
  • mFund
  • Managed Fund
  • Managed Fund Settlement Service
Notice reference number: 0054.18.01
Date published: 19/01/18
Effective as of: 22/01/18
Last updated: 19/01/18

The purpose of this ASX Notice is to inform ASX Market Participants of the admission of the New Capital China Equity Fund (ASX: NCE01) (the “Fund”) for settlement through the Managed Fund Settlement Service (“mFund”). This information is a summary only and ASX Market Participants are responsible for understanding the terms of the new Fund and should read the Product Disclosure Statement dated 22 January 2018 (“PDS”) before transacting in the Fund. The Fund will be admitted to mFund under the AQUA Rules framework. Market Participants should be aware of the differences between the AQUA rules and other rule frameworks. Further details regarding the AQUA rule framework can be found at: http://www.asx.com.au/documents/professionals/asx_aqua_rules_framework.pdf

Fund Name:

NEW CAPITAL CHINA EQUITY FUND

mFund Code:

NCE01

APIR Code:

ETL5779AU

APIR ISIN:

AU60ETL57790

Expected Commencement Date:

Monday, 22 January 2018

AQUA Product Issuer
Responsible Entity:

Equity Trustees Limited

Level 2, 575 Bourke Street

Melbourne VIC 3000, Australia

GPO Box 2307, Melbourne VIC 3001, Australia

T:+61 3 8623 5000

W: www.eqt.com.au

Investment Manager

EFG Asset Management (UK) Ltd

Leconfield House, Curzon Street

London W1J 5JB

T: + 44 20 74123894

W: www.newcapitalfunds.com

PISP/Unit Registry:         

Mainstream Fund Services Pty Ltd

Level 1, 51-57 Pitt Street

Sydney NSW 2000

 

T: 1300 133 451
W: www.mainstreamgroup.com

What do I need to do by when?

No action required.

Need more information?

Please refer to the PDS dated 22 January 2018.

Issued by

Karen Trau
Product Manager, Investment Products

Contact information

+61 (02)  9227 0000
info@asx.com.au

Disclaimer